- Home
- HAVA vs SXTC Comparison
HAVA vs SXTC Comparison
Compare HAVA & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$2.63
Company Overview
Basic Information| Metric | HAVA | SXTC |
|---|---|---|
| Founded | 2024 | 2005 |
| Country | South Korea | China |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 206.9M | 177.7M |
| IPO Year | 2025 | 2019 |
Fundamental Metrics
Financial Performance| Metric | HAVA | SXTC |
|---|---|---|
| Price | $10.00 | $2.63 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 103.1K | ★ 689.9K |
| Earning Date | 01-01-0001 | 08-19-2019 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,537,987.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.87 | $2.34 |
| 52 Week High | $10.01 | $1,175.99 |
Technical Indicators
Market Signals| Indicator | HAVA | SXTC |
|---|---|---|
| Relative Strength Index (RSI) | 62.40 | 60.66 |
| Support Level | $9.94 | $2.34 |
| Resistance Level | $10.01 | $6.40 |
| Average True Range (ATR) | 0.01 | 0.45 |
| MACD | 0.00 | 0.20 |
| Stochastic Oscillator | 85.69 | 41.00 |
Price Performance
Historical Comparison HAVA
SXTC
About HAVA Harvard Ave Acquisition Corporation Class A Ordinary Share
Harvard Ave Acquisition Corp is a blank check company.
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.